%0 Journal Article
%T The first six-month clinical outcomes and risk factors associated with high on-treatment platelet reactivity of clopidogrel in patients undergoing coronary interventions
%A Adnan Kaya
%A Ahmet Taha Alper
%A Ahmet £¿lker Tekke£¿in
%A Ayca G¨¹m¨¹£¿da£¿
%A Ceyhan T¨¹rkkan
%A Edibe Bet¨¹l Borklu
%A Emrah Bozbeyo£¿lu
%A Koray Kalendero£¿lu
%A Mert £¿lker Hay£¿ro£¿lu
%A Mustafa Adem Tatl£¿su
%A Yasin £¿ak£¿ll£¿
%A £¿zlem Y£¿ld£¿r£¿mt¨¹rk
%J Archive of "Anatolian Journal of Cardiology".
%D 2016
%R 10.14744/AnatolJCardiol.2016.6855
%X This study attempted to fill the gaps in evidence related to response to clopidogrel treatment in the Turkish population. The study aimed to determine the prevalence, associated risk factors, and clinical outcomes of high on-treatment platelet reactivity (HTPR) of clopidogrel in patients undergoing percutaneous coronary intervention (PCI) in a tertiary cardiovascular hospital in Turkey
%K high on-treatment platelet reactivity
%K clopidogrel
%K percutaneous coronary intervention
%K prevalence
%K risk factors
%U https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5324919/